LCM
GSK icon

Leisure Capital Management’s GSK GSK Stock Holding History

Leisure Capital Management’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-20,584
Closed -$882K – 141
2024
Q1 		$882K Sell
20,584
-335
-2% -$13.8K 0.44% 76
2023
Q4 		$775K Sell
20,919
-4,235
-17% -$152K 0.42% 75
2023
Q3 		$912K Buy
25,154
+1,262
+5% +$44.8K 0.52% 67
2023
Q2 		$852K Buy
23,892
+823
+4% +$29.5K 0.47% 74
2023
Q1 		$821K Buy
23,069
+2,168
+10% +$75.8K 0.47% 71
2022
Q4 		$734K Sell
20,901
-6,787
-25% -$226K 0.38% 84
2022
Q3 		$815K Sell
27,688
-346
-1% -$13.1K 0.49% 71
2022
Q2 		$1.52M Buy
28,034
+831
+3% +$45.9K 0.79% 33
2022
Q1 		$1.48M Buy
27,203
+397
+1% +$21.6K 0.75% 43
2021
Q4 		$1.48M Buy
+26,806
New +$1.39M 0.68% 48

Other funds holding GSK

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.2B AUM 37.55% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Holocene Advisors
Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return

Leisure Capital Management's GSK Position: Q2 2024 in Review

Leisure Capital Management sold out of GSK (GSK) in Q2 2024, closing a stake of 20,584 shares — an estimated $882K sold.

Leisure Capital Management first reported a position in GSK in Q4 2021 and held it in 10 quarters. The position peaked at $1.52M in Q2 2022. 884 funds tracked by Wall St. Rank hold GSK as of Q2 2024.

  • Leisure Capital Management reported no remaining GSK position as of Q2 2024 after selling out during the quarter.
  • Leisure Capital Management sold 20,584 GSK shares in Q2 2024, an estimated $882K.
  • Leisure Capital Management first reported a position in GSK in Q4 2021 and held it in 10 quarters.
  • Leisure Capital Management's GSK position peaked at $1.52M in Q2 2022.
  • 884 funds tracked by Wall St. Rank held GSK as of Q2 2024.

Based on Leisure Capital Management's 13F filing for Q2 2024, filed 26 Jul 2024.